All Releases
 |
AngioDynamics to Acquire Navilyst Medical for $372 Million
Jan 31, 2012
|
26.6 KB |
|
| |
AngioDynamics to host conference call today at 11:30 am ET
Increases Scale in Vascular Access and Peripheral Vascular Markets
Expands Product Portfolio and Adds Innovative Technologies
Strengthens Focus on Operational Excellence
Expected to be Accretive in FY13
ALBANY, N.Y. and MARLBOROUGH, M...
|
|
AngioDynamics Updates Financial Guidance for Fiscal Year 2012
Jan 24, 2012
|
17.2 KB |
|
| |
Company Implements Voluntary Recall of Ablation Zone Estimator Software on NanoKnife® Systems Installed in the U.S.
Resumption of NeverTouch® Procedure Kit Shipments Leads to Better Than Expected Demand
ALBANY, N.Y., Jan. 24, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally...
|
|
AngioDynamics to Present at the 30th Annual J.P. Morgan Healthcare Conference on January 12, 2012
Jan 6, 2012
|
9.0 KB |
|
| |
ALBANY, N.Y., Jan. 6, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif., on Thursday, January 12, 2012,...
|
|
AngioDynamics Reports Fiscal 2012 Second Quarter Financial Results
Jan 5, 2012
|
33.8 KB |
|
| |
ALBANY, N.Y., Jan. 5, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fiscal 2012 second quarter ended November 30, 2011.
Net sales in the second quarter ...
|
|
AngioDynamics to Report Fiscal 2012 Second Quarter Financial Results and Hold Conference Call on January 5, 2012
Dec 29, 2011
|
9.7 KB |
|
| |
ALBANY, N.Y., Dec. 29, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 second quarter financial results on Thursday, January 5, 2012, after the close o...
|
|
AngioDynamics Completes Enrollment in European NanoKnife® System Trial (ONC-208) for Pancreatic Cancer
Dec 21, 2011
|
12.0 KB |
|
| |
ALBANY, N.Y., Dec. 21, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the Company has completed patient enrollment in its European prospective NanoKnife® System trial (ONC-208) for the tr...
|
|
AngioDynamics to Present at the Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference on December 6, 2011
Nov 30, 2011
|
9.0 KB |
|
| |
ALBANY, N.Y., Nov. 30, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference in San ...
|
|
AngioDynamics to Present at Piper Jaffray Healthcare Conference on November 29, 2011
Nov 22, 2011
|
8.4 KB |
|
| |
ALBANY, N.Y., Nov. 22, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the Piper Jaffray Healthcare Conference on Tuesday, November 29, 2011, at 11:00 a.m. ET. Joseph M. DeVivo...
|
|
AngioDynamics Expands Senior Leadership Team
Nov 8, 2011
|
11.6 KB |
|
| |
ALBANY, N.Y., Nov. 8, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, appointed Matthew Kapusta, Senior Vice President of Business Development, effective November 15, 2011, and Donna Haire, Senior Vice P...
|
|
AngioDynamics Reports Fiscal 2012 First Quarter Financial Results
Oct 6, 2011
|
30.8 KB |
|
| |
Results Meet Company Guidance; Management Reiterates Full Fiscal Year Guidance
Authorizes Stock Repurchase Program
ALBANY, N.Y., Oct. 6, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease a...
|
|
AngioDynamics Receives Favorable Summary Judgment Order on Claims Against biolitec
Oct 3, 2011
|
11.0 KB |
|
| |
ALBANY, N.Y., Oct. 3, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the U.S. District Court for the Northern District of New York has granted key portions of AngioDynamics' motion for summary...
|
|
AngioDynamics Completes Enrollment in European NanoKnife® System Trial for Primary Liver Cancer
Sep 29, 2011
|
12.1 KB |
|
| |
ALBANY, N.Y., Sept. 29, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the Company has completed patient enrollment in its multi-center European prospective NanoKnife® System trial (ONC-2...
|
|
AngioDynamics to Report Fiscal 2012 First Quarter Financial Results and Hold Conference Call on October 6, 2011
Sep 29, 2011
|
9.7 KB |
|
| |
ALBANY, N.Y., Sept. 29, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 first quarter financial results on Thursday, October 6, 2011, after the close o...
|
|
Scott Solano to Depart AngioDynamics
Sep 22, 2011
|
8.2 KB |
|
| |
ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally
invasive medical devices for vascular access, surgery, peripheral
vascular disease and oncology, announced that Scott Solano, Senior Vice
President and Chief Technology Officer, has resigned his position
...
|
|
AngioDynamics Names Alan Panzer SVP, GM of Vascular Division
Sep 12, 2011
|
10.8 KB |
|
| |
ALBANY, N.Y., Sept. 12, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, has appointed Alan Panzer, 50, as Senior Vice President and General Manager of the Company's Vascular Division, effective September...
|
|
AngioDynamics to Present at CL King's 9th Annual Best Ideas Conference on September 13, 2011
Sep 6, 2011
|
8.4 KB |
|
| |
ALBANY, N.Y., Sept. 6, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, will present at CL King's 9th Annual Best Ideas Conference on Tuesday, September 13, 2011, at 2:15 p.m. ET. Joseph Gersuk, Executive Vice Presid...
|
|
AngioDynamics to Present at the Stifel Nicolaus Healthcare Conference on September 8, 2011
Aug 25, 2011
|
8.4 KB |
|
| |
ALBANY, N.Y., Aug. 25, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, will present at the Stifel Nicolaus Healthcare Conference on Thursday, September 8, 2011, at 3:15 p.m. ET. Joseph Gersuk, Executive Vice Preside...
|
|
AngioDynamics Names Joseph M. DeVivo President and CEO
Aug 16, 2011
|
13.4 KB |
|
| |
ALBANY, N.Y.--(BUSINESS WIRE)--
The Board of Directors of AngioDynamics (NASDAQ:ANGO), a leading
provider of innovative, minimally invasive medical devices for vascular
access, surgery, peripheral vascular disease and oncology, appointed
Joseph M. DeVivo President and Chief Executive Officer, effective Sept.
...
|
|
AngioDynamics Reports Fiscal 2011 Fourth Quarter and Full Year Financial Results
Jul 14, 2011
|
39.9 KB |
|
| |
Q4 Net Sales of $56.4 Million; 2011 Net Sales of $216.0 Million
Q4 NanoKnife® System
Sales Up 170% versus Year Ago Quarter; International Sales Rise 28%
versus Year Ago Quarter
Two Non-Cash Charges Totaling $6.4 Million Recorded in Q4
...
|
|
AngioDynamics to Report Fiscal 2011 Fourth Quarter and Full Year Financial Results and Hold Conference Call on July 14, 2011
Jul 5, 2011
|
8.8 KB |
|
| |
ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally
invasive medical devices for vascular access, surgery, peripheral
vascular disease and oncology, today announced that it will report its
fiscal 2011 fourth quarter and full year financial results on Thursday,
...
|
|
|
